In This Section

Program

Please note that this meeting will take place as an in-person event in San Diego, California and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program in progress.

FRIDAY, MARCH 7

Welcome and Opening Keynote Address

SATURDAY, MARCH 8

Sunday, March 9

Friday, March 7

REGISTRATION

4-8 p.m.

WELCOME AND Keynote Lectures

6-7 p.m.

Opening Reception

7:15-9:30 p.m.

Saturday, March 8

Continental Breakfast

7-8 a.m.

Plenary Session 1:  Cellular therapies in ALL

8-9:35 a.m.

  • Nirali Shah, National Institute of Health, Bethesda, Maryland
  • Rayne Rouce, Texas Children’s, Houston, Texas
  • Lori Muffly, Stanford University, Stanford, California

Break

9:35-9:50 a.m.

Plenary Session 2: B-ALL Biology

9:40-11:25 a.m.

  • Caner Saygin,  University of Chicago, Chicago, Illinois
  • Matt Witkowski, University of Colorado, Aurora, Colorado
  • Kara Davis, Stanford University, Stanford, California

Break

11:25-11:40 a.m.

Plenary Session 3 : Molecularly targeted therapies in ALL

11:40 a.m.-1:15 p.m.

  • Cristina Papayannidis, University of Bologna, Bologna, Italy
  • Wendy Stock, University of Chicago, Chicago, Illinois

Free time / Lunch on Own

1:15-2:45 p.m.

Plenary Session 4: T-ALL Biology

2:45-4:20 p.m.

  • Charles Mullighan, St. Jude’s Children’s Hospital, Memphis, Tennessee
  • Marc Mansour ,UCL, London
  • Daniel Herranz, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

Break

4:20-4:35 p.m.

Plenary Session 5: (Hematologic Malignancies Working Group Session)

4:35-6:05 p.m.

Spotlight on Proffered Papers Session

6:15-7 p.m.

Poster Session / Reception

7:15-9:15 p.m.

Sunday, March 9

Continental Breakfast

7-8 a.m.


Plenary Session 6: Targeted Immunotherapies in frontline therapies in ALL

8-9:35 a.m.

  • Sumit Gupta, Hospital for Sick Kids, Toronto, Ontario, Canada

Break

9:35-9:50 a.m.

Plenary Session 7 : Diagnostics and Prognostics in ALL

9:50-11:25 a.m.

  • Aaron Logan, University of California San Francisco, San Francisco, California
  • Jun Yang, St. Jude’s Children’s Hospital, Memphis, Tennessee

Break

11:25-11:40 a.m.

Plenary Session 8: Future direction in ALL therapy

11:40 a.m.-1: 15 p.m.

  • Elizabeth Raetz, New York University, New York, New York
  • Ibraham Aldoss, City of Hope, Irvine, California
  • Dave Teachey, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania

Closing Remarks

1:15-1:30 p.m.